ArticlebioRxiv : the preprint server for biology2025
Ionic Direct Current Enables Millimeter- and Millisecond-Scale Cortical Gain Control in vivo.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Precise, reversible modulation of cortical gain at mesoscale resolution remains a major challenge for neuroscience. Here, we introduce ionic direct current (iDC) delivered through non-penetrating electrolyte-filled microcatheters on the cortical surface as a method for targeted neuromodulation at millimeter spatial scales and millisecond onset/offset. In rat primary somatosensory cortex (S1HL), laminar recordings under urethane revealed that cathodic iDC attenuated and anodic iDC amplified both spontaneous delta oscillations and sensory-evoked responses, without causing time-locked spiking or state disruption. Computational modeling reproduced these effects and implicated dendritic summation at the axon initial segment as the mechanism for bidirectional gain control. In awake animals, iDC modulation of S1HL altered tactile sensitivity to Von Frey stimulation, demonstrating behavioral relevance. Together, these results establish iDC as a versatile platform for precise, rapidly reversible, and non-disruptive manipulation of cortical gain in vivo, enabling new approaches for dissecting mesoscale circuit interactions and linking column-scale physiology to behavior.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.